The [Intravenous (IV) Iron Therapy Market] is defined by its key applications, with chronic kidney disease (CKD) currently holding the largest share. This dominance is driven by the high prevalence of anemia in CKD patients, particularly those undergoing dialysis, where IV iron is an integral part of anemia management . However, the market is witnessing a significant shift,...
